findmyKOL

Rachel Kornik, MD

Basic profile

Dermatology

ORCIDNone on fileNPI
RegionSaint Albans, VT · NortheastSpecialtyDermatologyFocusDermatology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Rachel Kornik is a Dermatology physician. OpenAlex indexes 20 publications with 561 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
20publications

Distinct works indexed by OpenAlex.

561citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

53 Fairfax Rd
Saint Albans, VT 054784405

Telephone

802-582-4900

Provider last certified this registry record 27 Sept 2021.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    27.3%
    Corticosteroid13%
    Triamcinolone Acetonide82%Desoximetasone18%
    Part D89 patients
    Polyene Antifungal5.7%
    Nystatin100%
    Part D40 patients

    + 5 more classes in this area

  • Anti-infectives

    21.6%
    Azole Antifungal14.2%
    Ketoconazole86%Fluconazole14%
    Part D84 patients
    Tetracycline-class Drug3.4%
    Doxycycline Hyclate100%
    Part D26 patients

    + 2 more classes in this area

  • Cancer & immunology

    18.7%
    Nucleoside Metabolic Inhibitor13.5%
    Fluorouracil100%
    Part D141 patients
    Calcineurin inhibitor2.3%
    Tacrolimus100%
    Part D16 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”